SCHEMBL5677012

SCHEMBL5677012

CCCCc1cc(CCCC)c(OC(=O)O)c(O)c1CCC

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 3/20 0.38
PPARG P37231 2/20 0.36
PPARA Q07869 2/20 0.36
LDHA P00338 1/20 0.35
LDHB P07195 1/20 0.35
PTGES O14684 2/20 0.35
TOP2A P11388 1/20 0.35
PPARD Q03181 1/20 0.35
TYR P14679 1/20 0.35
GABRP O00591 1/20 0.35
GABRD O14764 1/20 0.35
GABRA1 P14867 1/20 0.35
GABRB1 P18505 1/20 0.35
GABRG2 P18507 1/20 0.35
GABRB3 P28472 1/20 0.35
GABRA5 P31644 1/20 0.35
GABRA3 P34903 1/20 0.35
GABRA2 P47869 1/20 0.35
GABRB2 P47870 1/20 0.35
GABRA4 P48169 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5920266 0.99 PPARG (0.38) ALOX5PPARGPPARALDHALDHB
SCHEMBL5680282 0.97 ALOX5 (0.42) ALOX5PPARGPPARAPTGESTOP2A
SCHEMBL5677849 0.96 LDHA (0.35) ALOX5PPARGPPARALDHALDHB
SCHEMBL5681172 0.96 ALOX5 (0.37) ALOX5PPARGPPARALDHALDHB
SCHEMBL5680436 0.96 ALOX5 (0.37) ALOX5PPARGPPARALDHALDHB
SCHEMBL5676145 0.94 ALOX5 (0.42) ALOX5PPARGPPARAPTGESTOP2A
SCHEMBL5678605 0.94 ALOX5 (0.42) ALOX5PPARGPPARAPTGESTOP2A
SCHEMBL5677054 0.94 NPC1 (0.37) ALOX5PPARGPPARALDHALDHB
SCHEMBL5680727 0.93 ALOX5 (0.41) ALOX5PPARGPPARAPTGESTOP2A
SCHEMBL5678629 0.93 ALOX5 (0.43) ALOX5PPARGPPARAPTGESTOP2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III ZHAO BAIYI 2006-02-16 US disclosed
EP-1620447-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III Exxonmobil Chemical Patents Inc. (US) 2006-02-01 EP disclosed
WO-2003102006-A1 SOLUBLE LATE TRANSITION METAL CATALYSTS FOR OLEFIN OLIGOMERIZATIONS III EXXONMOBIL CHEMICAL PATENTS INC. (US) 2003-12-11 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20060036049-A1 Soluble late transition metal catalysts for olefin oligomerizations III COMT, CD69, SPR ALOX5 833/4885PPARG 3732/4885PPARA 3398/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.